Switching from Ozempic to a generic: what changes in Canada?
What a generic is, who decides on a swap, how the pens differ, what plans pay, the 2026 recalls, and how the Ozempic savings card fits in.
Written for Canada. Other country versions are coming.
Generic semaglutide is the same medicine as Ozempic, approved by Health Canada for type 2 diabetes. Ontario and Alberta list it as interchangeable, so a pharmacist may swap it in and public plans pay the generic price. The pens look different, no generic comes in a 2 mg dose, and some lots were recalled in August 2026.
Key takeaways
- Health Canada calls generic semaglutide “pharmaceutically equivalent” to Ozempic, and approved the first one on 28 April 2026.1
- Ontario law lets a pharmacist give an interchangeable generic in place of a named brand unless the prescription says “no substitution”.2
- Ontario’s drug plan lists generic semaglutide at $78.14 a pen, against $227.94 for an Ozempic pen, and pays the generic price.3
- Every generic semaglutide pen approved so far gives 0.25 or 0.5 mg doses, or 1 mg doses; Ozempic also has a 2 mg pen.4,5,6,7,8
- Health Canada recalls in August 2026 covered several Dr. Reddy’s lots and one Apo-Semaglutide lot, and advised talking to a provider before stopping.9,10
On this page
Is generic semaglutide the same medicine as Ozempic?
Yes, the medicine inside is the same: semaglutide. Health Canada says the generics are “pharmaceutically equivalent” to the brand, Ozempic.1
- GLP‑1 medicines are prescription-only in Canada. Every product we mention is on Health Canada’s prescription schedule.11
- Label facts here come from the Canadian product monographs (the official label each maker files with Health Canada). Where we use another source, we say so.
- Every risk of these medicines is in Guide 5: Side effects and risks.
- This post describes rules, labels and trials. It isn’t a plan for your treatment, and no brand or dose guarantees any result.
The medicine is what works in your body. The brand is the name on the box. Acetaminophen is a medicine; Tylenol is one brand of it. Ozempic is Novo Nordisk’s brand of semaglutide, and a generic is the same medicine sold by another company once patents and data protection end.1
The way it’s made differs. Ozempic is made by yeast cells (recombinant DNA technology). The generic labels say their semaglutide is built by chemistry (“solid-phase synthetic chemistry”).8,4 Health Canada says its review checks that such differences “do not affect the safety, efficacy, or quality of the drug”.1
One label difference. The generic labels list one use: blood-sugar control in adults with type 2 diabetes.5,4 Ozempic’s Canadian label also covers lowering heart and kidney risk in some people with type 2 diabetes.8 None of these products is approved for weight loss; using them for that is off-label (outside the approved use).8,5
Who decides whether you get the generic?
Your prescriber and pharmacist, within your province’s rules. In Ontario, a pharmacist may give an interchangeable generic unless the prescription says “no substitution”.2
Each province decides which products are interchangeable (can be swapped by the pharmacist).
- Ontario: generic semaglutide is listed as interchangeable with Ozempic.3 The law lets the pharmacist swap a named brand for an interchangeable product, and you can ask for the swap yourself.2
- Alberta: generic semaglutide was added to the provincial drug list on 1 July 2026 as interchangeable with Ozempic, for type 2 diabetes.12
- Other provinces: we didn’t check every province’s list. Ask your pharmacist whether a generic is listed where you live.
Keeping the brand. A prescriber can write “no sub” or “no substitution” on the prescription, and the swap rules then don’t apply.2 If you ask for the brand yourself on Ontario’s drug plan, the pharmacy may charge you the difference.13
How are the generic pens different?
They work the same way, but they look different and come in fewer strengths. Each generic pen gives either 0.25 or 0.5 mg doses, or 1 mg doses.4,5,6,7
| Pen | Pens and the doses they give |
|---|---|
| Ozempic | Three pens: 0.25 or 0.5 mg; 1 mg; 2 mg8 |
| Generic semaglutide (Apotex, Aspen, Dr. Reddy’s, Sandoz) | Two pens: 0.25 or 0.5 mg (2 mg in the pen); 1 mg (4 mg in the pen)4,5,6,7 |
Canadian product monographs, checked 12 Oct 2026. Makers listed alphabetically, not ranked.
- No generic 2 mg pen. Ozempic has a pen that gives 2 mg doses.8 We found no generic pen that does.4,5,6,7
- Read the dose counter. The generic and Ozempic instructions both say: “Do not count the pen clicks.” Only the dose counter shows how much you’ve set.4,8
- Check the flow with each new pen. The instructions ask for a flow check before the first dose from every new pen.4
- Needles. The Apo-Semaglutide pack includes disposable needles: 6 with the lower-dose pen and 4 with the 1 mg pen.5
Ask the pharmacist to show you a new pen before your first dose from it. Our guide to brands and generics has the full list of approved products.
How much cheaper is the generic?
On Ontario’s public drug plan, a generic pen is $78.14 and an Ozempic pen is $227.94, so the generic is about a third of the price.3
Those are the prices the Ontario plan lists, not what every pharmacy charges at the counter.3 Health Canada says many generics in Canada are “45 to 90% cheaper” than the brand.1
A worked example. A year of weekly doses is 52 doses, or 13 four-dose pens. At the Ontario plan prices, that’s about $1,016 for the generic and $2,963 for Ozempic, before pharmacy fees. This is our arithmetic from the formulary prices.3
- Public plans pay the generic price. Ontario’s plan pays the generic price even when Ozempic is dispensed.3
- Private plans may follow. From 17 August 2026, Alberta Blue Cross private plans that use generic pricing pay the generic price for Ozempic claims.14
- Coverage stays the same. Public plans cover semaglutide for type 2 diabetes with conditions, not for weight loss.3,15 A generic doesn’t change that.
Compare brand and generic pens over a year, with your own pharmacy prices. No sign-up.
What is the Ozempic savings card?
It’s a discount program run by Novo Nordisk, Ozempic’s maker. It brings the brand’s price in line with generics for eligible people, outside Quebec.16,15
- Who: from 29 May 2026, eligible people with no drug coverage; from 6 July 2026, also eligible people with private coverage.15,16
- Where: pharmacies across Canada, excluding Quebec.16
- Why it exists: Novo Nordisk said the aim is to help patients “stay on the brand” as generics arrive.15
We don’t show the card’s price. It’s a coupon, not a list price, and the maker sets and changes the terms.16 Our post on GLP-1 prices in Canada covers the official prices.
Were any generic pens recalled?
Yes. In August 2026 Health Canada posted three recalls: two for Dr. Reddy’s semaglutide and one for Apo-Semaglutide.17,9,10
- Dr. Reddy’s, one lot: a 4 mg pen in a box labelled as a 2 mg pen.17
- Dr. Reddy’s, several lots: “an impurity is out of specification”.9
- Apo-Semaglutide, one lot: the pen may show and give a 2 mg dose instead of 0.25 or 0.5 mg.10
For each recall, Health Canada says to check whether your product is affected, and to consult your healthcare provider before stopping.9,10 Supply has also been patchy: Dr. Reddy’s reported a shortage from 10 July 2026.12 Our post on the 2026 recalls lists the lot numbers.
- Stomach effects are the most common. On the Wegovy label, 44 in 100 people felt sick (nausea), against 16 in 100 on a dummy injection.18
- Dehydration from vomiting or diarrhea can harm the kidneys, the Zepbound label warns.19
- Inflamed pancreas (pancreatitis): severe stomach pain that won’t go away needs medical help straight away.18
- Gallstones: 1.6 in 100 people on Wegovy, against 0.7 in 100 on a dummy injection.18
- Not for everyone: not with a personal or family history of medullary thyroid cancer or MEN 2 (a rare inherited condition), and stopped at least 2 months before a planned pregnancy.18
Questions people ask
Is Apo-Semaglutide the same as Ozempic?
It contains the same medicine, semaglutide, and Health Canada calls it “pharmaceutically equivalent” to Ozempic.1 Its label covers blood-sugar control in type 2 diabetes; Ozempic’s also covers heart and kidney risk.5,8
Can my pharmacist switch me to a generic without asking my doctor?
In Ontario, yes, if the generic is listed as interchangeable and the prescription doesn’t say “no substitution”.2,3 Other provinces have their own rules.
Is there a generic for the Ozempic 2 mg dose?
Not as of 12 Oct 2026. The approved generic pens give 0.25 or 0.5 mg doses, or 1 mg doses.4,5,6,7
Is generic semaglutide approved for weight loss?
The generic Ozempic copies are approved for type 2 diabetes only.5,4 Sevmia, a generic of Wegovy, is approved for weight management but wasn’t on sale on 12 Oct 2026.11,22
Can I use the Ozempic savings card in Quebec?
No. Novo Nordisk says the card works at pharmacies across Canada, excluding Quebec.16
Is Apo-Semaglutide the same as Ozempic? and Is there a generic Ozempic in Canada?
How we researched this
On 12 Oct 2026 we read Health Canada’s generic approval release, the Canadian labels (product monographs) for Ozempic and four generic semaglutide products, the August 2026 recall notices, Ontario’s interchangeability law and drug benefit law, and two Alberta Blue Cross bulletins.
Ontario plan prices come from the provincial formulary, checked on 12 Oct 2026 in our research pass. We name makers only as licence holders, in alphabetical order, and we don’t show savings-card or pharmacy prices. We didn’t check every province’s interchangeability list.
Before you move on
- Generic semaglutide is the same medicine as Ozempic, approved for type 2 diabetes.
- Your province decides whether a pharmacist can swap it in; a prescriber can write “no substitution”.
- Generic pens come in 0.25/0.5 mg and 1 mg versions only. Read the dose counter, not the clicks.
- Check the lot number of any semaglutide pen against Health Canada’s recall notices.
More from the Canada blog
The monthly Canada update
An independent guide to GLP‑1 medicines. We don't sell medicines, take drug-company money or earn clinic commissions. Once a month: coverage changes, approvals, safety notices and recalls. How we write
Sources
- Health Canada. Canada becomes the first G7 country to approve a generic version of semaglutide. News release, 28 April 2026. canada.ca
- Ontario. Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23, sections 4 and 5. ontario.ca
- Ontario Ministry of Health. Ontario Drug Benefit Formulary: semaglutide rows (Ozempic $227.94 a pen; generic semaglutide $78.141 a pen, interchangeable; Sevmia $325.048, off-formulary interchangeable). Checked 12 October 2026 by our research pass; the search page asked us for a captcha on a re-check, so we did not re-open it. formulary.health.gov.on.ca
- Dr. Reddy’s Laboratories. Semaglutide Injection product monograph, date of authorization 28 April 2026. Sections 6, 11 and instructions for use. pdf.hres.ca
- Apotex. Apo-Semaglutide Injection product monograph, date of authorization 1 May 2026. Sections 6, 11 and instructions for use. pdf.hres.ca
- Aspen Pharmacare Canada. Aspen-Semaglutide product monograph, date of authorization 17 July 2026 (pens delivering 0.25 or 0.5 mg, and 1 mg). pdf.hres.ca
- Sandoz Canada. Sandoz Semaglutide product monograph, date of authorization 16 September 2026 (pens delivering 0.25 or 0.5 mg, and 1 mg). pdf.hres.ca
- Novo Nordisk Canada. Ozempic (semaglutide injection) product monograph (the Canadian label), date of authorization 13 July 2026. Sections 1, 4.4, 4.5, 11 and patient information. pdf.hres.ca
- Health Canada recalls. Semaglutide Injection (Dr. Reddy’s): impurity out of specification, several lots. Last updated 26 August 2026. recalls-rappels.canada.ca
- Health Canada recalls. Apo-Semaglutide Injection: incorrect dose display, lot 7000599A. Last updated 27 August 2026. recalls-rappels.canada.ca
- Health Canada. Drug Product Database: product records and status for semaglutide, tirzepatide and liraglutide products (all on the prescription schedule; generic semaglutide products from Dr. Reddy’s and Apotex marketed in May 2026; Sevmia, Aspen and Sandoz products approved but not marketed). Searched 12 October 2026. health-products.canada.ca
- Alberta Blue Cross. Pharmacy Benefact 1330, July 2026 (generic semaglutide added to the Alberta Drug Benefit List from 1 July 2026, interchangeable with Ozempic; Dr. Reddy’s shortage from 10 July 2026). ab.bluecross.ca (PDF)
- Ontario. Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, section 6 (extra charge allowed when a specific interchangeable product is requested). ontario.ca
- Alberta Blue Cross. Pharmacy Benefact 1331, August 2026 (generic pricing for Ozempic claims under private plans that follow generic pricing, from 17 August 2026). ab.bluecross.ca (PDF)
- Global News (Canadian Press). Novo Nordisk to lower Ozempic price for some Canadians as generics arrive. 26 May 2026. globalnews.ca
- Novo Nordisk Canada. Ozempic Savings Card program expanded for patients with private coverage. Press release, 6 July 2026. novonordisk.ca (PDF)
- Health Canada recalls. Semaglutide Injection (Dr. Reddy’s): incorrect pen package, lot 7000544C (“contains a 4 mg pen but is labelled as a 2 mg pen”). Last updated 11 August 2026. recalls-rappels.canada.ca
- Novo Nordisk Canada. Wegovy (semaglutide injection) product monograph, date of authorization 2 October 2026. Sections 1, 2, 4.4, 4.5, 7, 8, 10, 11, 14 and patient information. pdf.hres.ca
- Eli Lilly Canada. Zepbound (tirzepatide injection) product monograph, date of authorization 11 June 2026. Sections 1, 4.4, 4.5, 8, 11, 14. pdf.hres.ca
- Health Canada. Canada launches new toll-free 1-844 POISON-X number for poison centres (Quebec keeps the Centre antipoison du Québec, 1-800-463-5060). News release, 20 March 2023. canada.ca
- Heart and Stroke Foundation of Canada. Medical services by phone (811 lines by province, including Info-Santé 811 in Quebec). Opened 12 October 2026. heartandstroke.ca
- Apotex. Sevmia (semaglutide injection) product monograph, date of authorization 29 June 2026. pdf.hres.ca
Last checked 12 Oct 2026 · Next review due 12 Apr 2027 · Report an error
How this post was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical, legal or tax advice. Talk to a qualified doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. How we write